Who we are
Innovate with us!
In 2025, approximately 9,000 employees worldwide were working in BASF's R&D units. Our global network of top universities, research institutes and companies gives us direct access to external scientific expertise, talented minds from various disciplines as well as new technologies. This strengthens our Research and Development Verbund and makes BASF an even more attractive partner and employer. In 2025, we collaborated with multiple companies as well as with 269 universities and research institutes. Join our network of innovators!
Make a new bond with BASF - The Chemistry of Collaboration
Collaboration is about Connection, Connection is about people. Who or what can we help you find? #Letscreatechemistry
What type of bond are you looking for?
Related News Releases:
Date
Results: 2162
BASF Group releases preliminary figures for second quarter of 2026 and increases earnings outlook for full-year 2026
BASF has released preliminary figures for the second quarter of 2026. Sales increased by 16% in the second quarter of 2026 to €17.2 billion (Q2 2025: €14.8 billion).
BASF expands certified biomass-balanced additives portfolio for architectural coatings
BASF is expanding its certified biomass balance (BMB) portfolio of additives for architectural coatings with the introduction of Dispex® AA 4145 MB, Rheovis® PU 1333 MB and Rheovis® HS 1169 MB.
BASF’s Care Chemicals division publishes Responsible Sourcing Report 2025
BASF is continuously advancing the responsible sourcing of renewable raw materials in its Care Chemicals division. The Responsible Sourcing Report 2025 shows how the company is strengthening environmental and social standards along global supply chains while supporting customers in their green transformation.
BASF and Carlyle complete coatings transaction
The coatings transaction between Carlyle and BASF announced on October 10, 2025, was completed on June 30, 2026, following receipt of all required regulatory approvals.
BASF and Bota Biosciences Introduce Bio-Identical Collagen III Powered by AI
BASF and Bota Biosciences jointly announced the market launch of BASF’s SkinNexus™ Collag3n. This 100% human-identical recombinant Collagen III fragment was developed in collaboration between the two companies and is being commercialized by BASF for the personal care market.